Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
80.74
-1.18 (-1.44%)
At close: Jul 24, 2026, 4:00 PM EDT
80.50
-0.24 (-0.29%)
After-hours: Jul 24, 2026, 7:39 PM EDT
Cytokinetics Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Cytokinetics stock has a consensus rating of "Buy" and an average price target of $107.8. The average 1-year stock price forecast is 33.51% higher than the current stock price, while the lowest is $83 (+2.80%) and the highest is $146 (+80.83%).
Price Target: $107.8 (+33.51%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cytokinetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 11 | 12 | 13 | 13 |
| Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 21 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $103 | Buy | Reiterates | $103 | +27.57% | Jul 23, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $83 | Hold | Maintains | $83 | +2.80% | Jul 22, 2026 |
| Citi | Citi | Buy Maintains $99 | Buy | Maintains | $99 | +22.62% | Jul 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $119 → $117 | Buy | Maintains | $119 → $117 | +44.91% | Jul 7, 2026 |
| UBS | UBS | Buy Upgrades $115 | Buy | Upgrades | $115 | +42.43% | Jun 29, 2026 |
Financial Forecast
Revenue This Year
112.87M
from 88.04M
Increased by 28.20%
Revenue Next Year
393.39M
from 112.87M
Increased by 248.53%
EPS This Year
-6.32
from -6.54
EPS Next Year
-4.68
from -6.32
EPS and Forward PE are based on non-GAAP adjusted numbers.